Figure S1.

This supplemental material reports the citations of all included studies in the literature review.

1: Abramson VG, Cooper Lloyd M, Ballinger T, Sanders ME, Du L, Lai D, Su Z, Mayer

I, Levy M, LaFrance DR, Vnencak-Jones CL, Shyr Y, Dahlman KB, Pao W, Arteaga CL.

Characterization of breast cancers with PI3K mutations in an academic practice

setting using SNaPshot profiling. Breast Cancer Res Treat. 2014

Jun;145(2):389-99. doi: 10.1007/s10549-014-2945-3. Epub 2014 Apr 11. PubMed PMID:

24722917; PubMed Central PMCID: PMC4046906.

2: Adams HR, Rose K, Augustine EF, Kwon JM, deBlieck EA, Marshall FJ, Vierhile A,

Mink JW, Nance MA. Experience, knowledge, and opinions about childhood genetic

testing in Batten disease. Mol Genet Metab. 2014 Feb;111(2):197-202. doi:

10.1016/j.ymgme.2013.10.017. Epub 2013 Nov 4. PubMed PMID: 24246680; PubMed

Central PMCID: PMC3919022.

3: Aiyar L, Shuman C, Hayeems R, Dupuis A, Pu S, Wodak S, Chitayat D, Velsher L,

Davies J. Risk estimates for complex disorders: comparing personal genome testing

and family history. Genet Med. 2014 Mar;16(3):231-7. doi: 10.1038/gim.2013.115.

Epub 2013 Sep 5. PubMed PMID: 24009002.

4: Akpinar A, Ersoy N. Attitudes of physicians and patients towards disclosure of

genetic information to spouse and first-degree relatives: a case study from

Turkey. BMC Med Ethics. 2014 May 16;15:39. doi: 10.1186/1472-6939-15-39. PubMed

PMID: 24885495; PubMed Central PMCID: PMC4029893.

5: Al-Farsi OA, Al-Farsi YM, Gupta I, Ouhtit A, Al-Farsi KS, Al-Adawi S. A study

on knowledge, attitude, and practice towards premarital carrier screening among

adults attending primary healthcare centers in a region in Oman. BMC Public

Health. 2014 Apr 17;14:380. doi: 10.1186/1471-2458-14-380. PubMed PMID: 24742222;

PubMed Central PMCID: PMC4004421.

6: Alderfer MA, Zelley K, Lindell RB, Novokmet A, Mai PL, Garber JE, Nathan D,

Scollon S, Chun NM, Patenaude AF, Ford JM, Plon SE, Schiffman JD, Diller LR,

Savage SA, Malkin D, Ford CA, Nichols KE. Parent decision-making around the

genetic testing of children for germline TP53 mutations. Cancer. 2015 Jan

15;121(2):286-93. doi: 10.1002/cncr.29027. Epub 2014 Sep 15. PubMed PMID:

25223899.

7: Alexander KM, Divine HS, Hanna CR, Gokun Y, Freeman PR. Implementation of

personalized medicine services in community pharmacies: perceptions of

independent community pharmacists. J Am Pharm Assoc (2003). 2014

Sep-Oct;54(5):510-7, 5 p following 517. doi: 10.1331/JAPhA.2014.13041. PubMed

PMID: 25148656.

8: Allyse M, Sayres LC, Goodspeed TA, Cho MK. Attitudes towards non-invasive

prenatal testing for aneuploidy among US adults of reproductive age. J Perinatol.

2014 Jun;34(6):429-34. doi: 10.1038/jp.2014.30. Epub 2014 Mar 6. PubMed PMID:

24603453; PubMed Central PMCID: PMC4399855.

9: Amiet C, Couchon E, Carr K, Carayol J, Cohen D. Are there cultural differences

in parental interest in early diagnosis and genetic risk assessment for autism

spectrum disorder? Front Pediatr. 2014 Apr 23;2:32. doi: 10.3389/fped.2014.00032.

eCollection 2014. PubMed PMID: 24795872; PubMed Central PMCID: PMC4006049.

10: Andersen MR, Thorpe J, Buist DS, Beatty JD, Watabayashi K, Hanson N, Resta R,

Chubak J, Urban N. Cancer Risk Awareness and Concern among Women with a Family

History of Breast or Ovarian Cancer. Behav Med. 2016;42(1):18-28. doi:

10.1080/08964289.2014.947234. Epub 2014 Nov 3. PubMed PMID: 25062114; PubMed

Central PMCID: PMC4469617.

11: Anderson AE, Flores KG, Boonyasiriwat W, Gammon A, Kohlmann W, Birmingham WC,

Schwartz MD, Samadder J, Boucher K, Kinney AY. Interest and informational

preferences regarding genomic testing for modest increases in colorectal cancer

risk. Public Health Genomics. 2014;17(1):48-60. doi: 10.1159/000356567. Epub 2014

Jan 14. PubMed PMID: 24435063; PubMed Central PMCID: PMC3992284.

12: Andrews V, Tonkin E, Lancastle D, Kirk M. Using the Diffusion of Innovations

theory to understand the uptake of genetics in nursing practice: identifying the

characteristics of genetic nurse adopters. J Adv Nurs. 2014 Apr;70(4):878-93.

doi: 10.1111/jan.12255. Epub 2013 Sep 15. PubMed PMID: 24102681.

13: André F, Bachelot T, Commo F, Campone M, Arnedos M, Dieras V, Lacroix-Triki

M, Lacroix L, Cohen P, Gentien D, Adélaide J, Dalenc F, Goncalves A, Levy C,

Ferrero JM, Bonneterre J, Lefeuvre C, Jimenez M, Filleron T, Bonnefoi H.

Comparative genomic hybridisation array and DNA sequencing to direct treatment of

metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).

Lancet Oncol. 2014 Mar;15(3):267-74. doi: 10.1016/S1470-2045(13)70611-9. Epub

2014 Feb 7. PubMed PMID: 24508104.

14: Arnold AG, Otegbeye E, Fleischut MH, Glogowski EA, Siegel B, Boyar SR,

Salo-Mullen E, Amoroso K, Sheehan M, Berliner JL, Stadler ZK, Kauff ND, Offit K,

Robson ME, Zhang L. Assessment of individuals with BRCA1 and BRCA2 large

rearrangements in high-risk breast and ovarian cancer families. Breast Cancer Res

Treat. 2014 Jun;145(3):625-34. doi: 10.1007/s10549-014-2987-6. Epub 2014 May 14.

PubMed PMID: 24825132.

15: Ashida S, Schafer EJ. Family health information sharing among older adults:

reaching more family members. J Community Genet. 2015 Jan;6(1):17-27. doi:

10.1007/s12687-014-0197-x. Epub 2014 Jul 30. PubMed PMID: 25074679; PubMed

Central PMCID: PMC4286562.

16: Ayme A, Viassolo V, Rapiti E, Fioretta G, Schubert H, Bouchardy C, Chappuis

PO, Benhamou S. Determinants of genetic counseling uptake and its impact on

breast cancer outcome: a population-based study. Breast Cancer Res Treat. 2014

Apr;144(2):379-89. doi: 10.1007/s10549-014-2864-3. Epub 2014 Feb 12. PubMed PMID:

24519389.

17: Badani KK, Thompson DJ, Brown G, Holmes D, Kella N, Albala D, Singh A, Buerki

C, Davicioni E, Hornberger J. Effect of a genomic classifier test on clinical

practice decisions for patients with high-risk prostate cancer after surgery. BJU

Int. 2015 Mar;115(3):419-29. doi: 10.1111/bju.12789. Epub 2014 Aug 11. PubMed

PMID: 24784420; PubMed Central PMCID: PMC4371645.

18: Bancroft EK, Castro E, Ardern-Jones A, Moynihan C, Page E, Taylor N, Eeles

RA, Rowley E, Cox K. "It's all very well reading the letters in the genome, but

it's a long way to being able to write": Men's interpretations of undergoing

genetic profiling to determine future risk of prostate cancer. Fam Cancer. 2014

Dec;13(4):625-35. doi: 10.1007/s10689-014-9734-3. PubMed PMID: 24980079.

19: Bar J, Cyjon A, Flex D, Sorotsky H, Biran H, Dudnik J, Peylan-Ramu N, Peled

N, Nechushtan H, Gips M, Katsnelson R, Rosenberg SK, Merimsky O, Onn A, Gottfried

M. EGFR mutation testing practice in advanced non-small cell lung cancer. Lung.

2014 Oct;192(5):759-63. doi: 10.1007/s00408-014-9604-7. Epub 2014 Jun 26. PubMed

PMID: 24964874.

20: Batte BA, Bruegl AS, Daniels MS, Ring KL, Dempsey KM, Djordjevic B, Luthra R,

Fellman BM, Lu KH, Broaddus RR. Consequences of universal MSI/IHC in screening

ENDOMETRIAL cancer patients for Lynch syndrome. Gynecol Oncol. 2014

Aug;134(2):319-25. doi: 10.1016/j.ygyno.2014.06.009. Epub 2014 Jun 14. PubMed

PMID: 24933100; PubMed Central PMCID: PMC4125501.

21: Beadles CA, Ryanne Wu R, Himmel T, Buchanan AH, Powell KP, Hauser E, Henrich

VC, Ginsburg GS, Orlando LA. Providing patient education: impact on quantity and

quality of family health history collection. Fam Cancer. 2014 Jun;13(2):325-32.

doi: 10.1007/s10689-014-9701-z. PubMed PMID: 24515581.

22: Beamon CJ, Hardisty EE, Harris SC, Vora NL. A single center's experience with

noninvasive prenatal testing. Genet Med. 2014 Sep;16(9):681-7. doi:

10.1038/gim.2014.20. Epub 2014 Mar 27. PubMed PMID: 24675675.

23: Beitsch PD, Whitworth PW. Can breast surgeons provide breast cancer genetic

testing? An American Society of Breast Surgeons survey. Ann Surg Oncol. 2014

Dec;21(13):4104-8. doi: 10.1245/s10434-014-3711-9. Epub 2014 Apr 23. PubMed PMID:

24756810.

24: Bell DA, Kirke AB, Barbour R, Southwell L, Pang J, Burrows S, Watts GF. Can

patients be accurately assessed for familial hypercholesterolaemia in primary

care? Heart Lung Circ. 2014 Dec;23(12):1153-7. doi: 10.1016/j.hlc.2014.06.015.

Epub 2014 Jul 5. PubMed PMID: 25065543.

25: Bell GC, Crews KR, Wilkinson MR, Haidar CE, Hicks JK, Baker DK, Kornegay NM,

Yang W, Cross SJ, Howard SC, Freimuth RR, Evans WE, Broeckel U, Relling MV,

Hoffman JM. Development and use of active clinical decision support for

preemptive pharmacogenomics. J Am Med Inform Assoc. 2014 Feb;21(e1):e93-9. doi:

10.1136/amiajnl-2013-001993. Epub 2013 Aug 26. PubMed PMID: 23978487; PubMed

Central PMCID: PMC3957400.

26: Benn P, Chapman AR, Erickson K, Defrancesco MS, Wilkins-Haug L, Egan JF,

Schulkin J. Obstetricians and gynecologists' practice and opinions of expanded

carrier testing and noninvasive prenatal testing. Prenat Diagn. 2014

Feb;34(2):145-52. doi: 10.1002/pd.4272. Epub 2013 Dec 16. PubMed PMID: 24222397.

27: Bensend TA, Veach PM, Niendorf KB. What's the harm? Genetic counselor

perceptions of adverse effects of genetics service provision by non-genetics

professionals. J Genet Couns. 2014 Feb;23(1):48-63. doi:

10.1007/s10897-013-9605-3. Epub 2013 Jun 12. PubMed PMID: 23754506.

28: Bernardes CM, Valery PC, Garvey G. Exploring the cancer risk perception and

interest in genetic services among Indigenous people in Queensland, Australia.

Aust N Z J Public Health. 2014 Aug;38(4):344-8. doi: 10.1111/1753-6405.12256.

Erratum in: Aust N Z J Public Health. 2015 Jun;39(3):292. PubMed PMID: 25091074.

29: Bernhardt BA, Kellom K, Barbarese A, Faucett WA, Wapner RJ. An exploration of

genetic counselors' needs and experiences with prenatal chromosomal microarray

testing. J Genet Couns. 2014 Dec;23(6):938-47. doi: 10.1007/s10897-014-9702-y.

Epub 2014 Feb 27. PubMed PMID: 24569858; PubMed Central PMCID: PMC4147030.

30: Blanchette PS, Spreafico A, Miller FA, Chan K, Bytautas J, Kang S, Bedard PL,

Eisen A, Potanina L, Holland J, Kamel-Reid S, McPherson JD, Razak AR, Siu LL.

Genomic testing in cancer: patient knowledge, attitudes, and expectations.

Cancer. 2014 Oct 1;120(19):3066-73. doi: 10.1002/cncr.28807. Epub 2014 Jun 24.

PubMed PMID: 24962202.

31: Bloss CS, Schork NJ, Topol EJ. Direct-to-consumer pharmacogenomic testing is

associated with increased physician utilisation. J Med Genet. 2014

Feb;51(2):83-9. doi: 10.1136/jmedgenet-2013-101909. Epub 2013 Dec 16. PubMed

PMID: 24343916.

32: Bombard Y, Miller FA, Hayeems RZ, Barg C, Cressman C, Carroll JC, Wilson BJ,

Little J, Avard D, Painter-Main M, Allanson J, Giguere Y, Chakraborty P. Public

views on participating in newborn screening using genome sequencing. Eur J Hum

Genet. 2014 Nov;22(11):1248-54. doi: 10.1038/ejhg.2014.22. Epub 2014 Feb 19.

PubMed PMID: 24549052; PubMed Central PMCID: PMC4200434.

33: Bombard Y, Rozmovits L, Trudeau M, Leighl NB, Deal K, Marshall DA. Access to

personalized medicine: factors influencing the use and value of gene expression

profiling in breast cancer treatment. Curr Oncol. 2014 Jun;21(3):e426-33. doi:

10.3747/co.21.1782. PubMed PMID: 24940102; PubMed Central PMCID: PMC4059806.

34: Borzekowski DL, Guan Y, Smith KC, Erby LH, Roter DL. The Angelina effect:

immediate reach, grasp, and impact of going public. Genet Med. 2014

Jul;16(7):516-21. doi: 10.1038/gim.2013.181. Epub 2013 Dec 19. PubMed PMID:

24357847.

35: Brannon Traxler L, Martin ML, Kerber AS, Bellcross CA, Crane BE, Green V,

Matthews R, Paris NM, Gabram SG. Implementing a screening tool for identifying

patients at risk for hereditary breast and ovarian cancer: a statewide

initiative. Ann Surg Oncol. 2014 Oct;21(10):3342-7. doi:

10.1245/s10434-014-3921-1. Epub 2014 Jul 22. PubMed PMID: 25047474.

36: Brewer NT, Defrank JT, Chiu WK, Ibrahim JG, Walko CM, Rubin P, Olajide OA,

Moore SG, Raab RE, Carrizosa DR, Corso SW, Schwartz G, Peppercorn JM, McLeod HL,

Carey LA, Irvin WJ Jr. Patients' understanding of how genotype variation affects

benefits of tamoxifen therapy for breast cancer. Public Health Genomics.

2014;17(1):43-7. doi: 10.1159/000356565. Epub 2014 Jan 22. PubMed PMID: 24457521;

PubMed Central PMCID: PMC4058990.

37: Brierley KL, Bonadies DC, Moyer A, Matloff ET. "Would you test your children

without their consent?" and other sticky dilemmas in the field of cancer genetic

testing. Fam Cancer. 2014 Sep;13(3):345-50. doi: 10.1007/s10689-014-9723-6.

PubMed PMID: 24804937.

38: Buchanan AH, Christianson CA, Himmel T, Powell KP, Agbaje A, Ginsburg GS,

Henrich VC, Orlando LA. Use of a patient-entered family health history tool with

decision support in primary care: impact of identification of increased risk

patients on genetic counseling attendance. J Genet Couns. 2015 Feb;24(1):179-88.

doi: 10.1007/s10897-014-9753-0. Epub 2014 Aug 15. PubMed PMID: 25120038.

39: Bui ET, Anderson NK, Kassem L, McMahon FJ. Do participants in genome

sequencing studies of psychiatric disorders wish to be informed of their results?

A survey study. PLoS One. 2014 Jul 1;9(7):e101111. doi:

10.1371/journal.pone.0101111. eCollection 2014. PubMed PMID: 24983240; PubMed

Central PMCID: PMC4077756.

40: Burstein MD, Robinson JO, Hilsenbeck SG, McGuire AL, Lau CC. Pediatric data

sharing in genomic research: attitudes and preferences of parents. Pediatrics.

2014 Apr;133(4):690-7. doi: 10.1542/peds.2013-1592. Epub 2014 Mar 10. PubMed

PMID: 24616359; PubMed Central PMCID: PMC3966500.

41: Buseh A, Kelber S, Millon-Underwood S, Stevens P, Townsend L. Knowledge,

group-based medical mistrust, future expectations, and perceived disadvantages of

medical genetic testing: perspectives of Black African immigrants/refugees.

Public Health Genomics. 2014;17(1):33-42. doi: 10.1159/000356013. Epub 2013 Dec

24. PubMed PMID: 24401187.

42: Butrick M, Kelly S, Peshkin BN, Luta G, Nusbaum R, Hooker GW, Graves K,

Feeley L, Isaacs C, Valdimarsdottir HB, Jandorf L, DeMarco T, Wood M, McKinnon W,

Garber J, McCormick SR, Schwartz MD. Disparities in uptake of BRCA1/2 genetic

testing in a randomized trial of telephone counseling. Genet Med. 2015

Jun;17(6):467-75. doi: 10.1038/gim.2014.125. Epub 2014 Sep 18. PubMed PMID:

25232856; PubMed Central PMCID: PMC4364924.

43: Cameron E, Rose S, Carey M. Assessment of family history of colorectal cancer

in primary care: perceptions of first degree relatives of people with colorectal

cancer. Patient Educ Couns. 2014 Mar;94(3):427-31. doi:

10.1016/j.pec.2013.11.014. Epub 2013 Dec 14. PubMed PMID: 24380670.

44: Cartwright T, Chao C, Lee M, Lopatin M, Bentley T, Broder M, Chang E. Effect

of the 12-gene colon cancer assay results on adjuvant treatment recommendations

in patients with stage II colon cancer. Curr Med Res Opin. 2014 Feb;30(2):321-8.

doi: 10.1185/03007995.2013.855183. Epub 2013 Nov 7. PubMed PMID: 24127781.

45: Caselli RJ, Langbaum J, Marchant GE, Lindor RA, Hunt KS, Henslin BR, Dueck

AC, Robert JS. Public perceptions of presymptomatic testing for Alzheimer

disease. Mayo Clin Proc. 2014 Oct;89(10):1389-96. doi:

10.1016/j.mayocp.2014.05.016. Epub 2014 Aug 26. PubMed PMID: 25171823; PubMed

Central PMCID: PMC4369785.

46: Chan SL, Low JJ, Chia KS, Wee HL. Attitudes on warfarin pharmacogenetic

testing in Chinese patients and public. Int J Technol Assess Health Care. 2014

Jan;30(1):113-20. doi: 10.1017/S026646231300069X. Epub 2014 Jan 27. PubMed PMID:

24468050.

47: Chan YM, Leung TY, Chan OK, Cheng YK, Sahota DS. Patient's choice between a

non-invasive prenatal test and invasive prenatal diagnosis based on test

accuracy. Fetal Diagn Ther. 2014;35(3):193-8. doi: 10.1159/000356075. Epub 2013

Nov 13. PubMed PMID: 24247224.

48: Christenhusz GM, Devriendt K, Peeters H, Van Esch H, Dierickx K. The

communication of secondary variants: interviews with parents whose children have

undergone array-CGH testing. Clin Genet. 2014 Sep;86(3):207-16. doi:

10.1111/cge.12354. Epub 2014 Mar 6. PubMed PMID: 24479378.

49: Christian S, Blumenschein P, Lilley M. An assessment of Canadian systems for

triaging referred out genetic testing. Clin Genet. 2015 Jul;88(1):90-4. doi:

10.1111/cge.12435. Epub 2014 Jul 26. PubMed PMID: 25065508.

50: Cichon M, Feldman GL. Opportunities to improve recruitment into medical

genetics residency programs: survey results of program directors and medical

genetics residents. Genet Med. 2014 May;16(5):413-8. doi: 10.1038/gim.2013.161.

Epub 2013 Oct 17. PubMed PMID: 24136619.

51: Comas C, Echevarria M, Rodríguez MA, Prats P, Rodríguez I, Serra B. Initial

experience with non-invasive prenatal testing of cell-free DNA for major

chromosomal anomalies in a clinical setting. J Matern Fetal Neonatal Med. 2015

Jul;28(10):1196-201. doi: 10.3109/14767058.2014.947579. Epub 2014 Aug 12. PubMed

PMID: 25048745.

52: Connor JA, Hinton RB, Miller EM, Sund KL, Ruschman JG, Ware SM. Genetic

testing practices in infants with congenital heart disease. Congenit Heart Dis.

2014 Mar-Apr;9(2):158-67. doi: 10.1111/chd.12112. Epub 2013 Jun 20. PubMed PMID:

23782710.

53: Cortesi L, Razzaboni E, Toss A, De Matteis E, Marchi I, Medici V, Tazzioli G,

Andreotti A, De Santis G, Pignatti M, Federico M. A rapid genetic counselling and

testing in newly diagnosed breast cancer is associated with high rate of

risk-reducing mastectomy in BRCA1/2-positive Italian women. Ann Oncol. 2014

Jan;25(1):57-63. doi: 10.1093/annonc/mdt422. Epub 2013 Nov 24. PubMed PMID:

24276029.

54: Costain G, Esplen MJ, Toner B, Scherer SW, Meschino WS, Hodgkinson KA,

Bassett AS. Evaluating genetic counseling for individuals with schizophrenia in

the molecular age. Schizophr Bull. 2014 Jan;40(1):78-87. doi:

10.1093/schbul/sbs138. Epub 2012 Dec 12. PubMed PMID: 23236078; PubMed Central

PMCID: PMC3885288.

55: Cousens NE, Gaff CL, Delatycki MB, Metcalfe SA. Prenatal β-thalassemia

carrier screening in Australia: healthcare professionals' perspectives of

clinical practice. Prenat Diagn. 2014 Mar;34(3):246-50. doi: 10.1002/pd.4297.

Epub 2014 Jan 19. PubMed PMID: 24338659.

56: Cragun D, Camperlengo L, Robinson E, Caldwell M, Kim J, Phelan C, Monteiro

AN, Vadaparampil ST, Sellers TA, Pal T. Differences in BRCA counseling and

testing practices based on ordering provider type. Genet Med. 2015

Jan;17(1):51-7. doi: 10.1038/gim.2014.75. Epub 2014 Jun 12. PubMed PMID:

24922460; PubMed Central PMCID: PMC4264999.

57: Cragun D, DeBate RD, Vadaparampil ST, Baldwin J, Hampel H, Pal T. Comparing

universal Lynch syndrome tumor-screening programs to evaluate associations

between implementation strategies and patient follow-through. Genet Med. 2014

Oct;16(10):773-82. doi: 10.1038/gim.2014.31. Epub 2014 Mar 20. PubMed PMID:

24651603; PubMed Central PMCID: PMC4169758.

58: Crawford JM, Bry L, Pfeifer J, Caughron SK, Black-Schaffer S, Kant JA,

Kaufman JH. The business of genomic testing: a survey of early adopters. Genet

Med. 2014 Dec;16(12):954-61. doi: 10.1038/gim.2014.60. Epub 2014 Jul 10. PubMed

PMID: 25010053; PubMed Central PMCID: PMC4262758.

59: Cuccaro ML, Czape K, Alessandri M, Lee J, Deppen AR, Bendik E, Dueker N,

Nations L, Pericak-Vance M, Hahn S. Genetic testing and corresponding services

among individuals with autism spectrum disorder (ASD). Am J Med Genet A. 2014

Oct;164A(10):2592-600. doi: 10.1002/ajmg.a.36698. Epub 2014 Aug 4. PubMed PMID:

25131847.

60: Cuevas-Cuerda D, Salas-Trejo D. Evaluation after five years of the cancer

genetic counselling programme of Valencian Community (Eastern Spain). Fam Cancer.

2014 Jun;13(2):301-9. doi: 10.1007/s10689-013-9693-0. PubMed PMID: 24242329.

61: Cuffe S, Hon H, Qiu X, Tobros K, Wong CK, De Souza B, McFarlane G, Masroor S,

Azad AK, Hasani E, Rozanec N, Leighl N, Alibhai S, Xu W, Issa AM, Liu G. Cancer

patients acceptance, understanding, and willingness-to-pay for pharmacogenomic

testing. Pharmacogenet Genomics. 2014 Jul;24(7):348-55. doi:

10.1097/FPC.0000000000000061. PubMed PMID: 24911662.

62: Cunningham F, Lewis S, Curnow L, Glazner J, Massie J. Respiratory physicians

and clinic coordinators' attitudes to population-based cystic fibrosis carrier

screening. J Cyst Fibros. 2014 Jan;13(1):99-105. doi: 10.1016/j.jcf.2013.06.009.

Epub 2013 Jul 25. PubMed PMID: 23891279.

63: Darst BF, Madlensky L, Schork NJ, Topol EJ, Bloss CS. Characteristics of

genomic test consumers who spontaneously share results with their health care

provider. Health Commun. 2014;29(1):105-8. doi: 10.1080/10410236.2012.717216.

Epub 2013 Feb 5. PubMed PMID: 23384116; PubMed Central PMCID: PMC3679226.

64: de Groot M, Wessel J. Genetic Testing and Type 2 Diabetes Risk Awareness.

Diabetes Educ. 2014 Mar 19;40(4):427-433. [Epub ahead of print] PubMed PMID:

24648440; PubMed Central PMCID: PMC4474775.

65: de Groot-van der Mooren MD, Gemke RJ, Cornel MC, Weijerman ME. Neonatal

diagnosis of Down syndrome in The Netherlands: suspicion and communication with

parents. J Intellect Disabil Res. 2014 Oct;58(10):953-61. doi: 10.1111/jir.12125.

Epub 2014 Mar 14. PubMed PMID: 24628769.

66: Dekker N, Hermens RP, de Wilt JH, van Zelst-Stams WA, Hoogerbrugge N; RISCO

study group. Improving recognition and referral of patients with an increased

familial risk of colorectal cancer: results from a randomized controlled trial.

Colorectal Dis. 2015 Jun;17(6):499-510. doi: 10.1111/codi.12880. PubMed PMID:

25524559.

67: Dhiman P, Kai J, Horsfall L, Walters K, Qureshi N. Availability and quality

of coronary heart disease family history in primary care medical records:

implications for cardiovascular risk assessment. PLoS One. 2014 Jan

9;9(1):e81998. doi: 10.1371/journal.pone.0081998. eCollection 2014. PubMed PMID:

24416135; PubMed Central PMCID: PMC3886986.

68: Dias MM, Ward HM, Sorich MJ, McKinnon RA. Exploration of the perceptions,

barriers and drivers of pharmacogenomics practice among hospital pharmacists in

Adelaide, South Australia. Pharmacogenomics J. 2014 Jun;14(3):235-40. doi:

10.1038/tpj.2013.31. Epub 2013 Sep 10. PubMed PMID: 24018620.

69: Dilzell K, Kingham K, Ormond K, Ladabaum U. Evaluating the utilization of

educational materials in communicating about Lynch syndrome to at-risk relatives.

Fam Cancer. 2014 Sep;13(3):381-9. doi: 10.1007/s10689-014-9720-9. PubMed PMID:

24770865.

70: Dodson C. Knowledge and attitudes of oncology nurses regarding

pharmacogenomic testing. Clin J Oncol Nurs. 2014 Aug;18(4):E64-70. doi:

10.1188/14.CJON.E64-E70. PubMed PMID: 25095306.

71: Doyle N, Cirino A, Trivedi A, Flynn M. Exploring barriers to payer

utilization of genetic counselors. J Genet Couns. 2015 Feb;24(1):122-33. doi:

10.1007/s10897-014-9745-0. Epub 2014 Aug 20. PubMed PMID: 25138080.

72: Edelman EA, Lin BK, Doksum T, Drohan B, Edelson V, Dolan SM, Hughes KS,

O'Leary J, Galvin SL, Degroat N, Pardanani S, Feero WG, Adams C, Jones R, Scott

J. Implementation of an electronic genomic and family health history tool in

primary prenatal care. Am J Med Genet C Semin Med Genet. 2014 Mar;166C(1):34-44.

doi: 10.1002/ajmg.c.31389. Epub 2014 Mar 10. PubMed PMID: 24616345.

73: Edelman EA, Lin BK, Doksum T, Drohan B, Edelson V, Dolan SM, Hughes K,

O'Leary J, Vasquez L, Copeland S, Galvin SL, DeGroat N, Pardanani S, Gregory

Feero W, Adams C, Jones R, Scott J. Evaluation of a novel electronic genetic

screening and clinical decision support tool in prenatal clinical settings.

Matern Child Health J. 2014 Jul;18(5):1233-45. doi: 10.1007/s10995-013-1358-y.

PubMed PMID: 24101435.

74: Eichmeyer JN, Burnham C, Sproat P, Tivis R, Beck TM. The value of a genetic

counselor: improving identification of cancer genetic counseling patients with

chart review. J Genet Couns. 2014 Jun;23(3):323-9. doi:

10.1007/s10897-013-9664-5. Epub 2013 Oct 25. PubMed PMID: 24155015.

75: Elliott AM, Chodirker BN, Bocangel P, Mhanni AA. Evaluation of a clinical

genetics service--a quality initiative. J Genet Couns. 2014 Oct;23(5):881-9. doi:

10.1007/s10897-014-9713-8. Epub 2014 Mar 21. PubMed PMID: 24647747.